AI in Healthcare 101: A Plain‑Language Glossary for Non‑Technical Founders

The headlines are impossible to ignore. From chatbots that promise to eliminate paperwork to clinical decision engines that sift millions of journal pages in seconds, artificial intelligence now dominates every healthcare conference and board meeting. Yet most founders and CEOs still admit—quietly, between sessions—that the terminology feels like a foreign language. Understanding that language is no longer optional. Investors want proof that you can navigate the hype, and customers expect you to translate technology into safer, faster, more affordable care.

This article delivers a straightforward glossary of essential AI concepts, framed for non‑technical leaders building companies in regulated health markets. It is not a textbook and it never drifts into math. Instead, it offers short, story‑driven explanations and real‑world vignettes so that you can ask sharper questions, recognise red flags, and map a realistic product roadmap. Read it end‑to‑end or dip into the sections that answer your most urgent doubts; either way, the goal is to raise your AI fluency without drowning you in jargon.

Understanding the Language of Healthcare AI

Before budgets are approved or pilots begin, every team must align on the meaning of a few foundational terms. Misunderstandings here compound into wasted sprints and expensive re‑writes later.

Artificial Intelligence, Machine Learning, and Deep Learning

Artificial intelligence (AI) is the umbrella concept: software that performs tasks we once believed only humans could handle—spotting patterns, making predictions, generating language. Within that broad field sits machine learning, which trains algorithms on historical data instead of hand‑coding every rule. Zoom in further and you reach deep learning, a branch that builds multi‑layered neural networks capable of recognising subtle patterns in X‑ray pixels or the rhythm of a clinician’s prose.

In practice, you rarely need to quote layer counts or activation functions. What matters is knowing that deep learning systems improve with data volume and that their decision pathways can be opaque. When a vendor claims “AI‑powered triage”, your next question should be: Which kind—rule‑based, classical ML, or deep neural—and how was it trained and validated on clinical data similar to mine?

Generative AI and Large Language Models

Generative AI moves beyond classifying or ranking information; it produces new text, images, even synthetic ECG traces. The workhorse of today’s generative wave is the large language model (LLM), a giant pattern‑predictor trained on billions of sentences. Give it a prompt, and it completes thoughts in the requested tone and format.

For a healthtech founder the immediate allure is documentation relief. Imagine a model that drafts a discharge summary in the style of your organisation’s templates, then adapts the language to a sixth‑grade reading level for the patient copy. The critical nuance: an LLM learns language, not ground truth. Left unchecked, it may invent laboratory values or cite journal articles that never existed. Responsible deployment therefore layers retrieval, guardrails, and human oversight on top of the raw model.

Retrieval‑Augmented Generation and Embeddings

Retrieval‑augmented generation (RAG) tackles hallucination risk by feeding the model only the information it should trust—policy manuals, formulary tables, recent visit notes—minutes before the answer is generated. The underlying mechanism is the embedding, a mathematical vector that captures the meaning of words or sentences. When your physician user asks, “Which antibiotics can I order for this patient with renal impairment?”, the system converts the query into an embedding, searches a vector database of guidelines, selects the best matches, and passes them back to the LLM as context. The result cites sources and remains grounded in local policy.

Founders choose RAG over full model fine‑tuning when they want lower cost, easier updates, and transparent citations. The trade‑off is extra engineering work: data pipelines must keep the document index fresh and secure.

Data Stewardship and Privacy

Every AI ambition in healthcare rises or falls on data quality and compliance. Impressive demos collapse once real, messy clinical data—and real regulation—enter the picture.

Protected Health Information and De‑Identification

Protected health information (PHI) is any data that can identify an individual while describing their past, present, or future health. Names and record numbers are obvious; less obvious are serial numbers of implanted devices or the patient’s full‑face photograph in a wound record. HIPAA allows two broad escape hatches: remove eighteen specific identifiers under the Safe Harbor method, or commission an expert determination that the re‑identification risk is very small. In either case, de‑identified data lies outside most HIPAA rules and can accelerate model training—provided contracts and ethical guidelines still control its use.

HIPAA, BAAs, and the Minimum‑Necessary Principle

Signing a Business Associate Agreement (BAA) with each covered entity customer is table stakes for vendors that touch PHI. The document pushes HIPAA obligations downstream, making you accountable for encryption, access controls, breach notification, and more. Yet compliance is more than a signature. The minimum‑necessary standard obliges you to collect and process only what is required for the task. A startup that uploads entire continuity‑of‑care documents to an external API, when it only needs the medication list, violates both security best practice and customer trust.

Auditability and Governance

Healthcare organisations may forgive a young company for a quirky interface; they will not forgive an opaque data trail. Audit logs must show who accessed which record, when, and why. Modern LLM workflows extend that requirement to prompts and responses. A governance layer that stores prompt text, retrieved documents, generated output, and user decisions creates a defensible trail for regulators and internal reviews. It is also the only way to discover silent drift—situations where the model’s tone, terminology, or accuracy degrades over months.

From Demo to Deployment

The gulf between a hack‑day proof of concept and a production clinical tool is wider than most pitch decks admit. Integration labour, latency budgets, and change‑management plans determine whether AI survives first contact with frontline users.

Integration Pathways: APIs, SDKs, and FHIR

An application programming interface (API) lets systems exchange data programmatically; a software development kit (SDK) wraps the same calls in convenience functions and examples. Both shrink build time, but healthcare integration still hinges on what travels through the pipe. Newer electronic health record systems support the FHIR standard, exposing medication orders or vital signs in predictable JSON bundles. Older sites rely on HL7 v2 messages delivered over dusty VPNs. Your AI feature must therefore speak multiple dialects or partner with an interface engine that does. Choosing the right integration path early saves quarters of re‑work later.

Building Trust: Guardrails, Drift Monitoring, Human Review

Guardrails enforce boundaries on inputs and outputs: stripping PHI from external prompts, blocking non‑formulary medication suggestions, constraining the model to a JSON schema that downstream applications can parse safely. Once live, the system needs drift monitors that test daily performance against a frozen benchmark dataset, alerting engineers when accuracy slips or costs spike. Finally, human‑in‑the‑loop workflows keep clinical accountability where it belongs. A nurse reviewer approving AI‑drafted prior‑authorization letters is slower than pure automation, but infinitely safer—and, crucially, defensible in court.

Measuring Value: Time to Value, Total Cost of Ownership, and Payback

Finance teams rarely object to pilots; they object to surprises at scale. Calculating total cost of ownership means adding usage‑based model fees, vector‑database storage, DevOps support, and the change‑management hours needed each time the EHR schema shifts. Against that cost you measure time saved per clinician, error reductions, or revenue reclaimed from overturned denials. Compressing the time to value—the span between kickoff and first measurable improvement—keeps board confidence high and reinforces a culture of disciplined experimentation.

Navigating the Regulatory Landscape

Healthcare AI crosses not one but several regulatory frontiers, and the map shifts by jurisdiction. A proactive stance turns compliance from blocker to competitive moat.

FDA and Software as a Medical Device

In the United States, the Food and Drug Administration regulates software that performs diagnosis, drives therapy decisions, or otherwise sits squarely in the clinical critical path. Classification as Software as a Medical Device (SaMD) triggers rigorous quality management and pre‑market submissions. Interestingly, language matters as much as code. If your marketing site claims the tool "identifies malignant lesions" the product may require 510(k) clearance; if the same algorithm is framed as a "triage prioritisation aid" it might evade that category. Engage regulatory counsel early, especially when AI output influences prescribing or treatment plans.

The EU AI Act and Global Trends

Europe’s upcoming AI Act sorts applications into risk tiers. Most clinical support tools sit in the high‑risk bucket, imposing transparency, human oversight, and post‑market monitoring obligations. Even if your first customers are American, the Act shapes the expectations of multinational health systems and investors who anticipate expansion. Parallel proposals in Canada, Brazil, and Singapore echo the same principles: document your data lineage, prove continuous safety, and provide a mechanism for human appeal.

Putting the Glossary to Work

Vocabulary is only powerful when woven into action. Start by circulating this article to product, engineering, compliance, and sales leads. Invite each function to highlight sections that feel uncertain or misaligned with current practice. The friction you surface in that exercise will reveal the real blockers to your next AI milestone—whether data availability, regulatory clarity, or user workflow.

Crafting Your First Pilot

Choose a single workflow where minutes saved translate directly into financial or clinical impact: an intake nurse call summary, a claims‑appeal draft, or a patient‑message triage queue. Confirm that you can access representative data sets, scrub or shield PHI appropriately, and measure baseline performance. Then assemble a four‑week sprint: Week 1 confirms objectives and success metrics; Week 2 cleans and labels data; Week 3 prototypes the model and interface; Week 4 gathers user feedback and calculates payback. Pilots framed this tightly create momentum and protect you from sprawling scope.

Sustaining Momentum

If the pilot clears safety and ROI gates, resist the temptation to launch five more features overnight. Instead, institutionalise the muscles you just exercised: establish an interdisciplinary AI review board, codify prompt templates in a shared library, and automate evaluation tests in your CI/CD pipeline. The vocabulary from this glossary becomes the shared shorthand that lets product managers brief engineers, lawyers interrogate vendors, and sales teams reassure cautious prospects.

{{lead-magnet}}

Conclusion

Healthcare will never abandon human expertise, but the organisations that thrive over the next decade will pair that expertise with machines that read, write, and reason at superhuman scale. Mastering the language of AI is the first step toward shaping those machines responsibly. Whether you keep this glossary on your desk or quote its definitions in tomorrow’s board deck, remember that technology alone solves nothing. Value emerges when clear words anchor clear goals, informed by the data, safeguards, and metrics that healthcare—rightly—demands.

Looking to go deeper than just definitions? We've designed the AI Implementation in Healthcare Masterclass to guide healthtech founders, product leaders, and CTOs through real-world decision frameworks, compliance strategies, and implementation architectures—based on Momentum’s work with over 50 healthcare companies.